Metagenomic Sequencing Market is estimated to increase at a Compounded Annual Growth Rate of 15.9% CAGR over the forecast period from 2024 to 2030
The Metagenomic Sequencing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Reagents and Consumables, Instruments, Sequencing Services, Analysis and Data Interpretation Solutions), By Workflow (Sample Preparation, Sequencing, Data Processing and Analysis), By Technology (16s Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Meta transcriptomics), By Type (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental, Veterinary, Others).
An Introduction to Metagenomic Sequencing Market in 2024
Metagenomic sequencing is a cutting-edge technology used to analyze genetic material from complex microbial communities, such as those found in the human microbiome or environmental samples. This market encompasses sequencing platforms, bioinformatics software, and data analysis tools specifically designed for metagenomics research. Advancements in metagenomic sequencing aim to unravel microbial diversity, identify novel species, characterize microbial functions, and elucidate microbial interactions, offering insights into human health, disease pathways, and ecological systems.
Market Trend: Expansion of Microbiome Research Across Industries
A prominent trend in the metagenomic sequencing market is the expansion of microbiome research across various industries. Metagenomic sequencing, which involves the analysis of microbial DNA extracted from complex environmental samples, has witnessed increasing adoption in fields such as healthcare, agriculture, environmental science, and food production. Researchers are exploring the role of the microbiome in human health and disease, soil fertility and crop productivity, ecosystem dynamics, and food safety. This trend is driven by advancements in sequencing technologies, bioinformatics tools, and data analysis methods, enabling researchers to characterize microbial communities, identify novel microorganisms, and uncover functional pathways and interactions within microbial ecosystems. As the understanding of the microbiome's impact on diverse industries deepens, the demand for metagenomic sequencing solutions for research and application-driven studies is expected to grow, driving market expansion and innovation in the metagenomic sequencing sector.
Market Driver: Increasing Demand for Personalized Medicine and Microbiome-based Therapeutics
A key driver fueling the demand for metagenomic sequencing is the increasing interest in personalized medicine and microbiome-based therapeutics. The human microbiome, comprising trillions of microorganisms residing in and on the human body, plays a critical role in maintaining health and modulating disease susceptibility. Metagenomic sequencing enables researchers to analyze the composition, diversity, and functional potential of the human microbiome, leading to insights into its role in health and disease. Furthermore, the identification of microbial signatures associated with various diseases, such as inflammatory bowel disease, obesity, and cancer, has spurred interest in microbiome-based diagnostics, therapeutics, and interventions. Metagenomic sequencing serves as a foundational tool for microbiome research, facilitating the discovery of biomarkers, development of targeted interventions, and optimization of microbiome-based therapies. As the field of microbiome-based medicine continues to advance, driven by growing evidence of the microbiome's impact on human health and disease, the demand for metagenomic sequencing solutions for clinical and translational research applications is expected to increase, driving market growth and adoption in the metagenomic sequencing market.
Market Opportunity: Integration with Precision Agriculture and Environmental Monitoring
A significant opportunity for the metagenomic sequencing market lies in the integration with precision agriculture and environmental monitoring. Microbial communities play essential roles in soil health, plant-microbe interactions, and ecosystem functioning, influencing crop productivity, nutrient cycling, and environmental resilience. Metagenomic sequencing enables farmers, agronomists, and environmental scientists to characterize soil microbiomes, assess microbial diversity and activity, and monitor changes in microbial communities over time. By leveraging metagenomic sequencing data, stakeholders in agriculture and environmental science can optimize soil management practices, enhance crop yield and quality, and mitigate environmental impacts such as soil erosion, nutrient runoff, and pesticide pollution. Additionally, metagenomic sequencing can be applied to environmental monitoring programs for assessing water quality, detecting microbial contaminants, and tracking microbial responses to environmental disturbances. Collaborating with agricultural companies, environmental agencies, and research institutions to develop tailored metagenomic sequencing solutions for precision agriculture and environmental monitoring presents opportunities for sequencing providers to address emerging needs, expand their market presence, and contribute to sustainable agriculture and environmental stewardship. By integrating metagenomic sequencing with precision agriculture and environmental monitoring workflows, sequencing providers can drive innovation, support data-driven decision-making, and unlock new opportunities in the dynamic and interdisciplinary field of microbiome research and environmental science.
Metagenomic Sequencing Market Share Analysis: Shotgun Metagenomic Sequencing for Clinical Diagnostics is the fastest growing segment over the forecast period to 2030
Among the segments listed, shotgun metagenomic sequencing for clinical diagnostics is experiencing rapid growth in the metagenomic sequencing market. This growth is primarily driven by the increasing demand for comprehensive and accurate methods to analyze microbial communities and their genetic content in clinical samples. Shotgun metagenomic sequencing allows for unbiased, high-throughput analysis of all microbial DNA present in a sample, providing insights into the composition, function, and potential pathogenicity of the microbiome. In clinical diagnostics, shotgun metagenomic sequencing is increasingly used for identifying infectious agents, characterizing antimicrobial resistance genes, and understanding the role of the microbiome in various diseases, including infectious diseases, inflammatory conditions, and cancer. Additionally, advances in sequencing technology and bioinformatics tools have improved the sensitivity, specificity, and turnaround time of shotgun metagenomic sequencing assays, making them valuable tools for precision medicine and personalized treatment strategies. As healthcare systems emphasize the importance of microbiome-based diagnostics and personalized healthcare approaches, the demand for shotgun metagenomic sequencing in clinical diagnostics is expected to continue growing rapidly.
Metagenomic Sequencing Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAzenta Life Sciences Inc, BGI Group, DNASTAR Inc, Eurofins Scientific, Illumina Inc, Integragen SA, Microsynth AG, Novogene Corp Co. Ltd, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, PerkinElmer Inc, Psomagen Inc, QIAGEN N.V., Tecan Group AG, Thermo Fisher Scientific Inc, Zymo Research Corp
Metagenomic Sequencing Market Segmentation
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Metagenomic Sequencing Market Companies
Azenta Life Sciences Inc
BGI Group
DNASTAR Inc
Eurofins Scientific
Illumina Inc
Integragen SA
Microsynth AG
Novogene Corp Co. Ltd
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Tecan Group AG
Thermo Fisher Scientific Inc
Zymo Research Corp
Reasons to Buy the Metagenomic Sequencing Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Metagenomic Sequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Metagenomic Sequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Metagenomic Sequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Metagenomic Sequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 Metagenomic Sequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Metagenomic Sequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Metagenomic Sequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Metagenomic Sequencing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Metagenomic Sequencing Industry
4.2 Key Market Trends in Metagenomic Sequencing Industry
4.3 Potential Opportunities in Metagenomic Sequencing Industry
4.4 Key Challenges in Metagenomic Sequencing Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Metagenomic Sequencing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Metagenomic Sequencing Market Outlook by Segments
7.1 Metagenomic Sequencing Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
8 North America Metagenomic Sequencing Market Analysis and Outlook To 2030
8.1 Introduction to North America Metagenomic Sequencing Markets in 2024
8.2 North America Metagenomic Sequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Metagenomic Sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
9 Europe Metagenomic Sequencing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Metagenomic Sequencing Markets in 2024
9.2 Europe Metagenomic Sequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Metagenomic Sequencing Market Size Outlook by Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
10 Asia Pacific Metagenomic Sequencing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Metagenomic Sequencing Markets in 2024
10.2 Asia Pacific Metagenomic Sequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Metagenomic Sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
11 South America Metagenomic Sequencing Market Analysis and Outlook To 2030
11.1 Introduction to South America Metagenomic Sequencing Markets in 2024
11.2 South America Metagenomic Sequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Metagenomic Sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
12 Middle East and Africa Metagenomic Sequencing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Metagenomic Sequencing Markets in 2024
12.2 Middle East and Africa Metagenomic Sequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Metagenomic Sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Azenta Life Sciences Inc
BGI Group
DNASTAR Inc
Eurofins Scientific
Illumina Inc
Integragen SA
Microsynth AG
Novogene Corp Co. Ltd
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Tecan Group AG
Thermo Fisher Scientific Inc
Zymo Research Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
